Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

Recruiting N/A Interventional Study
Telomeric 22Q13 Monosomy Syndrome Tuberous Sclerosis Hamartoma Syndrome, Multiple Fragile X Syndrome Angelman Syndrome Rett Syndrome Chromosome 15Q, Partial Deletion Creatine Deficiency, X-linked
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 – 12
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
92 (estimated)
Sponsor
Rush University Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate communication and behavioral strategies in individuals with syndromic intellectual and developmental disorders. Participants will be asked to complete virtual study assessments at intake and then on a monthly basis for the durat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age(s) 2-12 years old at time of enrollment * Existing genetic syndrome based on clinical or genetic diagnosis and confirmed by medical records * Documented diagnosis of global developmental delay (GDD) or intellectual disability (ID) * estimated ID in all ranges * Disruptive …
Contacts

Latha Soorya, PhD

312-942-3767

Latha_Soorya@rush.edu

CONTACT

Allison Wainer, PhD

Allison_Wainer@rush.edu

CONTACT